CTOs on the Move

Mesoblast

www.mesoblast.com

 
Mesoblast is a world leader in developing innovative cellular medicines. We have established what we believe is the industry`s most clinically advanced and diverse portfolio of cell-based products with five programs, two of which are partnered, in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2. All our clinical programs target significant, under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.mesoblast.com
  • 505 Fifth Avenue Level 3
    New York, NY USA 10017
  • Phone: 212.880.2060

Executives

Name Title Contact Details

Similar Companies

Mosaic Biosciences

Mosaic`s biopharmaceutical teams turn ideas into reality. We provide experienced biopharma leadership and cross-functional teams to accelerate your protein therapeutic research and development program

NeuroVasc Technologies

NeuroVasc Technologies is a developer of mechanical thrombectomy solutions for revascularization of the brain.

Cara Therapeutics

Learn more about Cara Therapeutics, a biotechnology company focusing on pharmaceutical product development for better pruritus and pain management.

Access Genetics LLC

Access Genetics LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

STRM.BIO